APA
Rogado J., Romero-Laorden N., Sanchez-Torres J. M., Ramos-Levi A. M., Pacheco-Barcia V., Ballesteros A. I., Arranz R., Lorenzo A., Gullon P., Garrido A., Serra López-Matencio J. M., Donnay O., Adrados M., Costas P., Aspa J., Alfranca A., Mondejar R. & Colomer R. (20210714). Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies. : Oncoimmunology.
Chicago
Rogado Jacobo, Romero-Laorden Nuria, Sanchez-Torres José Miguel, Ramos-Levi Ana María, Pacheco-Barcia Vilma, Ballesteros Ana Isabel, Arranz Reyes, Lorenzo Alicia, Gullon Pedro, Garrido Ana, Serra López-Matencio José María, Donnay Olga, Adrados Magdalena, Costas Pablo, Aspa Javier, Alfranca Arantzazu, Mondejar Rebeca and Colomer Ramon. 20210714. Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies. : Oncoimmunology.
Harvard
Rogado J., Romero-Laorden N., Sanchez-Torres J. M., Ramos-Levi A. M., Pacheco-Barcia V., Ballesteros A. I., Arranz R., Lorenzo A., Gullon P., Garrido A., Serra López-Matencio J. M., Donnay O., Adrados M., Costas P., Aspa J., Alfranca A., Mondejar R. and Colomer R. (20210714). Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies. : Oncoimmunology.
MLA
Rogado Jacobo, Romero-Laorden Nuria, Sanchez-Torres José Miguel, Ramos-Levi Ana María, Pacheco-Barcia Vilma, Ballesteros Ana Isabel, Arranz Reyes, Lorenzo Alicia, Gullon Pedro, Garrido Ana, Serra López-Matencio José María, Donnay Olga, Adrados Magdalena, Costas Pablo, Aspa Javier, Alfranca Arantzazu, Mondejar Rebeca and Colomer Ramon. Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies. : Oncoimmunology. 20210714.